company ONCO - SteadyBase

steadybase-$ company ONCO

account_id none on file

legal_name Onconetix, Inc.

ticker ONCO

cik 1782107

domain onconetix.com

linkedin_company_url none on file

entry_point_account_id none on file

name Onconetix Inc.

exchange Nasdaq

sector Health Care

irhttps://ir.onconetix.com/

sector index/company/sector/health-care/

calls 0 filings 10 executives 4 family 0

why_nownone on file

callsnone on file

filings

As such, the Company may take additional measures to reduce expenses in order to conserve its cash in amounts sufficient to sustain operations and meet its obligations, or, if it is required to, file for bankruptcy.

filing / Aug 13, 2026 / receipt

cost reduction efforts and in connection with our initial pause in commercializing ENTADFI, we terminated three employees involved with

filing / Aug 13, 2026 / receipt

Additionally, a partial termination of a prior lease amendment further reduced the office space. This lease expired on December 31, 2025 , and was renewed for a successive two-year term, resulting in an additional right-of-use asset and lease liability of approximately $ 49,000 .

filing / Aug 13, 2026 / receipt

Office Lease Proteomedix leases office and lab space in Zurich Switzerland. In May 2025, Proteomedix entered into a lease amendment to reduce its leased premises.

filing / Aug 13, 2026 / receipt

Based on that evaluation, our Chief Executive Officer and Chief Financial Officer has concluded that the Company’s disclosure controls and procedures were not effective as of June 30, 2026, as a result of the material weaknesses described below.

filing / Aug 13, 2026 / receipt

In addition, as part of cost reduction efforts and in connection with our initial pause in commercializing ENTADFI, we terminated